GSK Conducting PGx Trials for Newly Approved Tykerb; Monogram eTag Assays May Play Role (GenomeWeb News)
GlaxoSmithKline is hoping that pharmacogenomic studies of its newly approved targeted breast cancer drug Tykerb will help identify patients with other solid tumors likely to respond to the drug.
posted by (hris @ 5:20 AM
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home